BASIC AYURVEDA
⚠️ High Risk
FEI: 3008489902 • Ghaziabad, Uttar Pradesh • INDIA
FEI Number
3008489902
Location
Ghaziabad, Uttar Pradesh
Country
INDIAAddress
46 Anand Industrial Estate, Mohan Nagar, Ghaziabad, Uttar Pradesh, India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
STD IDENT
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(g)(1) of the FD&C Act in that the article purports to be or is represented as a food for which a definition and standard of identity have been prescribed by regulations as provided by section 401 of the FD&C Act and the article does not conform to such definition and standard.
JUICE %
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that the food purports to be a beverage containing vegetable or fruit juice and does not bear a statement on the label in appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained therein.
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
DIETARYING
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(A) of the FD&C Act in that the dietary supplement label or labeling fails to list the name of each dietary ingredient of the supplement and the quantity of each such dietary ingredient or , with respect to a proprietary blend of such dietary ingredients, the total quantity of all dietary ingredients in the blend.
HEALTH C
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 5/17/2024 | 66VDR99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/26/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 10/26/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 10/26/2019 | 54FBA10GARLIC (HERBAL & BOTANICALS, NOT TEAS) | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 10/26/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 10/26/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 10/26/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 10/26/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 10/26/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 10/26/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 10/26/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 10/26/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 9/16/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Division of Northeast Imports (DNEI) | |
| 9/16/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Division of Northeast Imports (DNEI) | |
| 9/16/2019 | 54FRT99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Division of Northeast Imports (DNEI) | |
| 7/18/2011 | 20DHT01BLACKBERRY JUICE, BERRY JUICE OR CONCENTRATES | Southwest Import District Office (SWI-DO) | |
| 7/18/2011 | 20DHT08GOOSEBERRY JUICE, BERRY JUICE OR CONCENTRATES | Southwest Import District Office (SWI-DO) | |
| 7/18/2011 | 30GHT99BEVERAGE BASE OF NON-FRUIT ORIGIN, LIQUID, N.E.C. | Southwest Import District Office (SWI-DO) | |
| 7/18/2011 | 20DHT01BLACKBERRY JUICE, BERRY JUICE OR CONCENTRATES | Southwest Import District Office (SWI-DO) | |
| 7/18/2011 | 20DHT08GOOSEBERRY JUICE, BERRY JUICE OR CONCENTRATES | Southwest Import District Office (SWI-DO) |
Frequently Asked Questions
What is BASIC AYURVEDA's FDA import refusal history?
BASIC AYURVEDA (FEI: 3008489902) has 20 FDA import refusal record(s) in our database, spanning from 7/18/2011 to 5/17/2024.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. BASIC AYURVEDA's FEI number is 3008489902.
What types of violations has BASIC AYURVEDA received?
BASIC AYURVEDA has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about BASIC AYURVEDA come from?
All FDA import refusal data for BASIC AYURVEDA is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.